This inventor holds 1 USPTO granted patent. Top assignee: Yonsei University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Won Joo Kim in Cancer Treatment
Introduction
Won Joo Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of genetic research, particularly in the area of cancer treatment. His innovative work focuses on the KRAS gene, which is known to play a critical role in various cancers.
Latest Patents
Won Joo Kim holds a patent titled "Guide RNA complementary to KRAS gene, and use thereof." This patent includes a guide RNA, a vector comprising the same, and a composition for removing a nucleic acid sequence encoding a KRAS polypeptide in the genome of a cell. Additionally, it encompasses a composition for preventing or treating cancer and a method utilizing these components. The invention enables the mutation of a nucleic acid sequence encoding a KRAS polypeptide, which can be particularly useful in personalized or precision medical care for cancer prevention or treatment.
Career Highlights
Won Joo Kim is affiliated with Yonsei University, where he conducts his research and development activities. His work has garnered attention for its potential impact on cancer therapies, making him a notable figure in the scientific community.
Collaborations
He has collaborated with esteemed colleagues, including Hyong Bum Kim and Han Sang Kim, to advance research in this critical area of medicine.
Conclusion
Won Joo Kim's innovative contributions to cancer treatment through his patent on KRAS gene targeting exemplify the potential of genetic research in personalized medicine. His work continues to inspire advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile